Effects of supplementation with fish oil-derived n-3 fatty acids and γ-linolenic acid on circulating plasma lipids and fatty acid profiles in women

American Journal of Clinical Nutrition

Volumn 77, Issue 1, 2003, Pages 37-42

  Laidlaw, Maggie ^a   Holub, Bruce J ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Arachidonic acid; DHA; Dihomo linolenic acid; Docosahexaenoic acid; Eicosapentaenoic acid; EPA; HDL cholesterol; LDL cholesterol; N 3 fatty acids; Triacylglycerols; Women; linolenic acid

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FAT INTAKE; FEMALE; HEART INFARCTION; HEART PROTECTION; HUMAN; LIPID BLOOD LEVEL; LIPID DIET;

EID: 0037215310     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/77.1.37     Document Type: Article

References (46)

1. Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease: Predicting risks by levels and ratios. Ann Intern Med 1994;121:641-7.
2. Lamarche B, Lewis GF. Atherosclerosis prevention for the next decade: Risk assessment beyond low density lipoprotein cholesterol. Can J Cardiol 1998;14:841-51.
3. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 1997;96:2520-5.
4. Cui Y, Blumenthal RS, Flaws JA, et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001;161:1413-9.
5. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998;81:7B-12B.
6. Sharrett AR, Sorlie PD, Chambless LE, et al. Relative importance of various risk factors for asymptomatic carotid atherosclerosis versus coronary heart disease incidence - The Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999;149:843-52.
7. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138:S419-20.
8. Meydani M. Nutrition, immune cells, and atherosclerosis. Nutr Rev 1998;56:S177-82.
9. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
10. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nut 2000; 71(suppl):343S-8S.
11. Crawford M. Background to essential fatty acids and their prostanoid derivative. Br Med Bull 1983;39:210-3.
12. Hwang D. Essential fatty acids and immune response. FASEB J 1989; 3:2052-61.
13. Fan Y, Chapkin R. Importance of dietary γ-linolenic acid in human health and nutrition. J Nutr 1998:128:1411-4.
14. Rubin D, Laposata M. Cellular interactions between n-6 and n-3 acids: A mass analysis of fatty acid elongation/desaturation, distribution among complex lipids and conversion to eicosanoids. J Lipid Res 1992;33:1431-40.
15. Graham J, Franks S, Bonney RC. In vivo and in vitro effects of gamma-linolenic acid and eicosapentaenoic acid on prostaglandin production and arachidonic acid uptake by human endometrium. Prostaglandins Leukot Essent Fatty Acids 1994;50:321-9.
16. Ishikawa T, Fujiyama Y, Igarishi O, et al. Effects of gamma linolenic acid on plasma lipoproteins and apoproteins. Atherosclerosis 1989; 75:95-104.
17. Cleland L, Gibson R, Neumann M, French J. The effect of dietary fish oil supplement upon the content of dihomo-gamma linoleic acid in human platelet phospholipids. Prostaglandins Leukot Essent Fatty Acids 1990;40:9-12.
18. Tocher D, Bell J, Farndale B, Sargent J. Effects of dietary γ-linolenic acid-rich borage oil combined with marine fish oils on tissue phospholipid fatty acid composition and production of prostaglandins E and F of the 1-, 2- and 3-series in a marine fish deficient in delta fatty acyl desaturase. Prostaglandins Leukot Essent Fatty Acids 1997;57:125-34.
19. Chapkin RS, Somers SD, Erickson KL. Dietary manipulation of macrophage phospholipid classes: Selective increase of dihomo gamma linolenic acid. Lipids 1988;23:766-70.
20. Barham J, Edens M, Fonteh A, Johnson M, Easter L, Chilton F. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in human serum. J Nutr 2000;130:1925-31.
21. Torres I, Mira L, Ornelas C, Melim A. Study of the effects of dietary fish intake on serum lipids and lipoproteins in two populations with different dietary habits. Br J Nutr 2000;83:371-9.
22. Nestel P. Fish oil and cardiovascular disease: Lipids and arterial function. Am J Clin Nutr 2000;71(suppl):228S-31S.
23. Suzakawa M, Abbey M, Howe P, Nesten P. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J Lipid Res 1995;36:473-84.
24. Harris WS. n-3 Fatty acids and serum lipoproteins: Human studies. Am J Clin Nutr 1997;65(suppl):1645S-54S.
25. Guivernau M, Meza N, Barja P, Roman O. Clinical and experimental study on the long-term effect of dietary gamma-linolenic acid on plasma lipids, platelet aggregation, thromboxamine formation and prostacyclin production. Prostaglandins Leukot Essent Fatty Acids 1994;51:311-6.
26. von Schacky C. n-3 Fatty acids and the prevention of coronary atherosclerosis. Am J Clin Nutr 2000;71(suppl):224S-7S.
27. Stark K, Park E, Maines V, Holub B. Effect of a fish-oil concentrate on serum lipids in post-menopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled double-blind study. Am J Clin Nutr 2000;72:389-94.
28. Zurier RB, Rossetti RG, Jacobson EW, et al. Gamma-linolenic acid treatment of rheumatoid arthritis. Arthritis Rheum 1996;39:1808-17.
29. Johnson M, Swan D, Surette M, et al. Dietary supplementation with γ-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr 1997;127:1435-44.
30. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem 1972;18:499-502.
31. Andersen LF, Solvell K, Drevon CA. Very-long-chain fatty acids as biomarkers for intake of fish and n-3 fatty acid concentrates. Am J Clin Nutr 1996;64:305-11.
32. Bonaa KH, Bjerve KS, Nordoy A. Habitual fish consumption, plasma phospholipid fatty acids, and serum lipids: The Tromso Study. Am J Clin Nutr 1992;55:1126-340.
33. Holub BJ. Skeaff CM. Nutritional regulation of cellular phosphatidylinositol. Methods Enzymol 1987;141:234-44.
34. Dattilo A, Kris-Etherton P. Effects of weight reduction on blood lipids and lipoproteins: A meta-analysis. Am J Clin Nutr 1992;56:320-8.
35. Boberg M, Vessby B, Selinus I. Effects of dietary supplementation with n-6 and n-3 long-chain polyunsaturated fatty acids on serum lipoproteins and platelet function in hypertriglyceridaemic patients. Acta Med Scand 1986;220:153-60.
36. Assmann G. Pro and con: High-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management. Am J Cardiol 2001;87(suppl):2-7.
37. Bruunsgard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol 2001;8:131-6.
38. Calder PC. n-3 Polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 1997;41:203-34.
39. James MJ, Cleland LG. Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum 1997;27:85-97.
40. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991;54:438-63.
41. Fan YY, Ramos KS, Chapkin RS. Modulation of atherogenesis by dietary gamma-linolenic acid. Adv Exp Med Biol. 1999;469:485-91.
42. Rothman D, DeLuca, P, Zurier RB. Botanical lipids: Effects on inflammation, immune responses and rheumatoid arthritis. Semin Arthritis Rheum 1995;25:87-96.
43. Kremer JM. Effects of modulation of inflammatory and immune parameters in patients with rheumatic and inflammatory disease receiving dietary supplementation of n-3 and n-6 fatty acids. Lipids 1996;31:S243-7.
44. Alexander JW. Immunonutrition: The role of omega-3 fatty acids. Nutrition 1998;14:627-33.
45. Simon JA, Hodgkins ML, Browner WS, Neuhaus JM, Bernert JT Jr, Hulley SB. Serum fatty acids and the risk of coronary heart disease. Am J Epidemiol 1995;142:469-76.
46. Krauss RM, Eckel RH, Howard B, et al. AHA dietary guidelines. Revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000;102:2284-99.